Enanta Pharmaceuticals, Inc. (ENTA)
14.64
+0.46
(+3.24%)
USD |
NASDAQ |
Dec 09, 16:00
14.62
-0.02
(-0.14%)
After-Hours: 20:00
Enanta Pharmaceuticals Total Assets (Quarterly): 292.72M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
| Theriva Biologics, Inc. | 30.84M |
| Oragenics, Inc. | 12.71M |
| NanoViricides, Inc. | 8.357M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 228.00M |
| Shareholders Equity (Quarterly) | 64.72M |
| Debt to Equity Ratio | 3.107 |
| Current Ratio | 4.208 |
| Net Debt Paydown Yield | 1.96% |